Biocartis Group NV (BR:BCART) — Stock Price
Biocartis Group NV (BR:BCART) is currently trading at €0.29 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.29 and €0.29. This page tracks Biocartis Group NV's live share price on the BR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Biocartis Group NV (BCART) market capitalisation.
Biocartis Group NV (BCART) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Biocartis Group NV's daily closing share price and trading volume on the BR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Biocartis Group NV Income Statement — Revenue, Profit & Earnings by Year
Biocartis Group NV's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Total Revenue | €57.48 Million | €48.27 Million | €43.13 Million | €37.44 Million | €27.81 Million |
| Cost of Revenue | €29.80 Million | €33.92 Million | €26.28 Million | €21.33 Million | €15.35 Million |
| Gross Profit | €27.68 Million | €14.35 Million | €16.84 Million | €16.12 Million | €12.46 Million |
| Research & Development | €38.39 Million | €43.95 Million | €45.78 Million | €39.84 Million | €36.84 Million |
| SG&A | €3.52 Million | €3.32 Million | €3.16 Million | €5.25 Million | €2.59 Million |
| Total Operating Expenses | €74.73 Million | €76.64 Million | €63.23 Million | €71.46 Million | €59.26 Million |
| Operating Income | €-47.05 Million | €-62.30 Million | €-46.38 Million | €-55.34 Million | €-46.86 Million |
| EBITDA | €-44.33 Million | €-52.55 Million | €-43.23 Million | €-47.35 Million | €-42.17 Million |
| EBIT | €-54.43 Million | €-62.64 Million | €-46.86 Million | €-55.60 Million | €-46.44 Million |
| Interest Expense | €21.18 Million | €9.32 Million | €10.18 Million | €7.10 Million | €1.36 Million |
| Income Before Tax | €-65.62 Million | €-71.72 Million | €-63.16 Million | €-64.17 Million | €-48.26 Million |
| Income Tax Expense | €-240.00K | €-243.00K | €-228.00K | €-99.00K | €-109.00K |
| Net Income | €-65.38 Million | €-71.47 Million | €-62.93 Million | €-64.07 Million | €-48.15 Million |
Biocartis Group NV Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Biocartis Group NV's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Total Assets | €114.28 Million | €142.48 Million | €210.52 Million | €268.32 Million | €139.38 Million |
| Total Current Assets | €69.93 Million | €95.13 Million | €159.98 Million | €214.63 Million | €90.78 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €1.20 Million | — | €-426.00K | €-13.00K | — |
| Net Receivables | €17.91 Million | €23.35 Million | €18.91 Million | €13.21 Million | €9.74 Million |
| Inventory | €18.91 Million | €16.11 Million | €15.71 Million | €14.16 Million | €11.92 Million |
| Property, Plant & Equipment | €31.53 Million | €37.19 Million | €40.10 Million | €43.42 Million | €30.39 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €144.56 Million | €176.38 Million | €173.69 Million | €183.84 Million | €52.03 Million |
| Total Current Liabilities | €42.45 Million | €33.70 Million | €29.45 Million | €23.18 Million | €20.28 Million |
| Long-term Debt | €92.71 Million | €128.15 Million | €125.26 Million | €136.22 Million | €16.45 Million |
| Net Debt | €97.43 Million | €101.84 Million | €28.09 Million | €-24.45 Million | €-27.00 Million |
| Total Stockholder Equity | €-30.28 Million | €-33.90 Million | €36.82 Million | €84.48 Million | €87.35 Million |
| Retained Earnings | €-443.36 Million | €-526.40 Million | €-455.34 Million | €-397.55 Million | €-328.14 Million |
Biocartis Group NV Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Biocartis Group NV generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-44.85 Million | €-65.72 Million | €-39.27 Million | €-54.25 Million | €-41.99 Million |
| Capital Expenditures | €1.94 Million | €3.75 Million | €3.02 Million | €2.52 Million | €5.83 Million |
| Free Cash Flow | €-46.79 Million | €-69.47 Million | €-42.29 Million | €-56.77 Million | €-47.82 Million |
| Investing Cash Flow | €-5.43 Million | €-3.75 Million | €-4.01 Million | €-5.50 Million | €-5.82 Million |
| Financing Cash Flow | €22.46 Million | €-1.20 Million | €-11.52 Million | €175.02 Million | €-1.51 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €640.00K | €760.00K | €1.43 Million | €1.23 Million | €1.06 Million |
| Depreciation | €10.48 Million | €9.85 Million | €9.75 Million | €9.72 Million | €4.27 Million |
| Change in Cash | €-27.40 Million | €-70.15 Million | €-55.06 Million | €115.19 Million | €-49.23 Million |
Biocartis Group NV Earnings History — EPS Actual vs. Analyst Estimates
Track Biocartis Group NV's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 26, 2023 | -0.34 | 0.00 | — |
| Feb 23, 2023 | -0.79 | — | — |
| Oct 20, 2022 | 0.00 | 0.00 | — |
| Sep 01, 2022 | -0.50 | — | — |
| Apr 19, 2022 | 0.00 | 0.00 | — |
| Feb 24, 2022 | -1.26 | 0.00 | — |
| Nov 10, 2021 | 0.00 | 0.00 | — |
| Aug 26, 2021 | -0.65 | 0.00 | — |